Process for the synthesis of 5- (methyl1H-imidazol-1-yl) -3- (trifluoromethyl) - benzeneamine

Details for Australian Patent Application No. 2006258116 (hide)

Owner Novartis AG

Inventors Shieh, Wen-Chung; Garcia Fuentes, Pedro; Vicente Banos, Francisco; Martin Medina, Jose; Xue, Song; Acemoglu, Murat; Schenkel, Berthold; Widmer, Erich

Agent Davies Collison Cave

Pub. Number AU-B-2006258116

PCT Pub. Number WO2006/135619

Priority 60/688,920 09.06.05 US

Filing date 7 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 25 November 2010

International Classifications

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/135619 Priority application(s): WO2006/135619

25 November 2010 Application Accepted

  Published as AU-B-2006258116

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258117-Vapor phase hydrogen peroxide deodorizer

2006258110-Method of improving dispersant efficacy in making gypsum products